Related Experiment Videos
Engineering and characterization of functional human microvessels in immunodeficient mice
J E Nör1, M C Peters, J B Christensen
1Department of Cariology, Restorative Sciences, and Endodontics, School of Dentistry, University of Michigan, Ann Arbor, USA.
Summary
Researchers developed a novel human angiogenesis model using human dermal microvascular endothelial cells in SCID mice. This model enables the study of microvessel development and therapeutic strategies for neovascularization.
Area of Science:
- Biomedical Engineering
- Angiogenesis Research
- Tissue Engineering
Background:
- Current in vivo angiogenesis models utilize nonhuman endothelial cells, limiting direct human physiological relevance.
- Advances in tissue engineering and molecular biology enable the potential for engineering human microvessels in vivo.
Purpose of the Study:
- To establish a functional human angiogenesis model in vivo using human dermal microvascular endothelial cells (HDMEC) in severe combined immunodeficient (SCID) mice.
- To investigate the potential for engineering functional human microvessels for research and therapeutic applications.
Main Methods:
- Transplantation of HDMEC onto biodegradable polymer matrices into SCID mice.
- Stable transduction of HDMEC with Flag epitope or alkaline phosphatase for human origin confirmation.
- Monitoring of microvessel formation, differentiation, and anastomosis with host vasculature over 10-21 days.
Main Results:
- HDMEC successfully differentiated into functional human microvessels within 7-10 days post-transplantation.
- Formed human microvessels anastomosed with the mouse vasculature and expressed key angiogenesis markers (CD31, CD34, VCAM-1, ICAM-1).
- Human endothelial cells were invested by mouse perivascular cells, indicating functional integration.
Conclusions:
- The developed SCID mouse model provides a platform for studying human angiogenesis in vivo.
- This model is suitable for investigating microvessel development, tumor angiogenesis, and strategies for enhancing neovascularization in engineered tissues.